Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Protein S deficiency is a disorder that causes abnormal blood clotting. When someone bleeds, the blood begins a complicated series of rapid chemical reactions involving proteins called blood coagulation factors to stop the bleeding. Other proteins in the blood, such as protein S, usually regulate these chemical reactions to prevent excessive clotting. When protein S is missing (deficient), clotting may not be regulatednormally and affected individuals have an increased risk of forming a blood clot called a thrombosis. People at risk to haveprotein S deficiency are those with an individual or family history of multiple blood clots in the veins. Treatment may include taking medication known as blood thinners to decrease the chance of developing a blood clot.
Biomarker and diagnostic research for protein S deficiency has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
90 publications have been identified in PubMed for protein S deficiency. Research spans Case Report / Case Series (53%), Review / Meta-Analysis (14%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 48 | 53% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
Genetic and Rare Diseases Info Center
Research summaries |
13 |
14% |
Disease patterns and progression | 12 | 13% |
Clinical study results | 7 | 8% |
Testing and diagnosis research | 5 | 6% |
Laboratory research | 3 | 3% |
Other research | 2 | 2% |
Liu Y (2026). [PMID: 42051428](https://pubmed.ncbi.nlm.nih.gov/42051428/). *Front Cardiovasc Med*. [Case Report / Case Series]
Nicola A (2026). [PMID: 41964057](https://pubmed.ncbi.nlm.nih.gov/41964057/). *Thromb J*. [Clinical Trial Publication]
Hou Z (2026). [PMID: 41967715](https://pubmed.ncbi.nlm.nih.gov/41967715/). *J Thromb Haemost*. [Basic Science / Preclinical]
Song J (2026). [PMID: 42186519](https://pubmed.ncbi.nlm.nih.gov/42186519/). *J Surg Case Rep*. [Case Report / Case Series]
Balbi Caruso N (2026). [PMID: 42158783](https://pubmed.ncbi.nlm.nih.gov/42158783/). *Cureus*. [Case Report / Case Series]
Yu S (2026). [PMID: 42108743](https://pubmed.ncbi.nlm.nih.gov/42108743/). *Ann Lab Med*. [Other]
Soulimani D (2026). [PMID: 42185143](https://pubmed.ncbi.nlm.nih.gov/42185143/). *Vasc Dis (Paris)*. [Epidemiology / Natural History]
Tinkle MB (2026). [PMID: 41481204](https://pubmed.ncbi.nlm.nih.gov/41481204/). *Journal of the American Association of Nurse Practitioners*. [Diagnostic / Biomarker]
Bakhshipour F (2026). [PMID: 42200097](https://pubmed.ncbi.nlm.nih.gov/42200097/). *Int J Reprod Biomed*. [Epidemiology / Natural History]
Bartylla MM (2026). [PMID: 42079676](https://pubmed.ncbi.nlm.nih.gov/42079676/). *Res Pract Thromb Haemost*. [Review / Meta-Analysis]